eFT508 |
A potent inhibitor of MNK1 and MNK2 (IC50s = 50 = <50 nM); has a half-life… |
5 mg |
21957-5 |
More Info
|
EG 018 |
An analog of JWH 018 that has a benzene ring attached to the aminoalkylind… |
1 mg |
15533-1 |
More Info
|
EG 018 |
An analog of JWH 018 that has a benzene ring attached to the aminoalkylind… |
10 mg |
15533-10 |
More Info
|
EG 018 |
An analog of JWH 018 that has a benzene ring attached to the aminoalkylind… |
5 mg |
15533-5 |
More Info
|
EGA |
A inhibitor of endosomal trafficking; increases accumulation of fluorescen… |
1 mg |
21882-1 |
More Info
|
EGA |
A inhibitor of endosomal trafficking; increases accumulation of fluorescen… |
10 mg |
21882-10 |
More Info
|
EGA |
A inhibitor of endosomal trafficking; increases accumulation of fluorescen… |
25 mg |
21882-25 |
More Info
|
EGA |
A inhibitor of endosomal trafficking; increases accumulation of fluorescen… |
5 mg |
21882-5 |
More Info
|
EGF (human, recombinant) |
Source: Active recombinant human EGF expressed in E. coli • Amino aci… |
1 mg |
32057-1 |
More Info
|
EGF (human, recombinant) |
Source: Active recombinant human EGF expressed in E. coli • Amino aci… |
100 µg |
32057-100 |
More Info
|
EGF (human, recombinant; Fc-tagged) |
Source: Active recombinant N-terminal human IgG1 Fc-tagged EGF expressed i… |
1 mg |
32025-1 |
More Info
|
EGF (human, recombinant; Fc-tagged) |
Source: Active recombinant N-terminal human IgG1 Fc-tagged EGF expressed i… |
100 µg |
32025-100 |
More Info
|
EGFR/ErbB2 Inhibitor |
A cell-permeable inhibitor of EGFR and c-ErbB2 (IC50s = 20 and 79 nM, resp… |
1 mg |
17568-1 |
More Info
|
EGFR/ErbB2 Inhibitor |
A cell-permeable inhibitor of EGFR and c-ErbB2 (IC50s = 20 and 79 nM, resp… |
5 mg |
17568-5 |
More Info
|
EGFR Extracellular Domain (human, recombinant) |
Source: Active recombinant C-terminal human IgG1 Fc-tagged EGFR extracellu… |
1 mg |
32026-1 |
More Info
|
EGFR Extracellular Domain (human, recombinant) |
Source: Active recombinant C-terminal human IgG1 Fc-tagged EGFR extracellu… |
100 µg |
32026-100 |
More Info
|
EGFR Inhibitor |
A cell permeable, selective inhibitor of the EGFR kinase (IC50s = 21, 63,… |
1 mg |
15363-1 |
More Info
|
EGFR Inhibitor |
A cell permeable, selective inhibitor of the EGFR kinase (IC50s = 21, 63,… |
25 mg |
15363-25 |
More Info
|
EGFR Inhibitor |
A cell permeable, selective inhibitor of the EGFR kinase (IC50s = 21, 63,… |
5 mg |
15363-5 |
More Info
|
EGFR Peptide (human, mouse) (myristoylated) (trifluoroacetate salt) |
A PKC inhibitor (IC50 = 5 µM); reverses resistance to doxorubicin in… |
10 mg |
36897-10 |
More Info
|
EGFR Peptide (human, mouse) (myristoylated) (trifluoroacetate salt) |
A PKC inhibitor (IC50 = 5 µM); reverses resistance to doxorubicin in… |
100 mg |
36897-100 |
More Info
|
EGFR Peptide (human, mouse) (myristoylated) (trifluoroacetate salt) |
A PKC inhibitor (IC50 = 5 µM); reverses resistance to doxorubicin in… |
5 mg |
36897-5 |
More Info
|
EGFR Peptide (human, mouse) (myristoylated) (trifluoroacetate salt) |
A PKC inhibitor (IC50 = 5 µM); reverses resistance to doxorubicin in… |
50 mg |
36897-50 |
More Info
|
EGFR Peptide (human, mouse) (trifluoroacetate salt) |
A peptide substrate of PKC; has been used to monitor PKC activity in prima… |
1 mg |
36896-1 |
More Info
|
EGFR Peptide (human, mouse) (trifluoroacetate salt) |
A peptide substrate of PKC; has been used to monitor PKC activity in prima… |
10 mg |
36896-10 |
More Info
|